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ABSTRACT: Hepatitis B surface antigen was measured by enzyme immunoassay in a random 
sample of 1258 healthy pregnant women attending the ante-natal clinics of St. Luke's Hospital, 
Malta and Gozo General Hospital, Gozo, and 364 intravenous drug users attending the 
detoxification centre, SLH. Eight of the pregnant women and ten of the drug addicts were positive 
for the surface antigen, accounting for a prevalence of 6/1000 and 30/1000 for each cohort, 
respectively. This would be consistent with low/intermediate prevalence rate in accordance with 
WHO criteria. 
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Introduction 
Hepatitis B is an important cause of acute and chronic 
infection of the liver with a long incubation period of 
approximately 2-4 months 1.2. Hepatocellular damage is 
mediated by the cellular immune response of the host to 
the hepatocytes3. Persistence of the virus occurs in 
about 10% of adults .and in as many as 90% of infants 
due to their underdeveloped immune system4. The 
hepatitis B carrier state is defined as the presence of 
hepatitis B surface antigen (HBsAg) in the serum for 
more than six months 1•5• There are approximately 200 
million carriers worldwide, who provide a reservoir for 
the disease, and who have an increased risk of cirrhosis 
and hepatocellular carcinoma 1.4.5. 
There is a spectrum of disease from subclinical 
infection to an acute icteric illnessI.2. The virus is 
primarily transmitted via the parenteral route, thus 
placing intra-venous drug abusers at risk. In addition, 
the infection may be transmitted sexually, perinatally 
and possibly, by close contact due to non-sexual 
exchange of body f1uids 3.6 . 
The only previous work on hepatitis B, known to the 
authors, to have been carried out in Malta, was a study 
on Maltese blood donors 7• In this study, blood donors 
constituted two sUb-populations: one largely composed 
of relatives of hospital patients who required blood, 
while the other consisted essentially of voluntary donors 
many of whom were already screened and therefore 
selectively tending to be negative. The prevalence of 
hepatitis in the first group was reported as 2.8% and in 
the latter, as 0.6%. The author of that study commented 
that both results may be overestimates because the 
ELlSA method then used may have given a relatively 
high false positive rate and no further confim1atory tests 
were done. The author recommended a further study 
with confim1atory tests. 
Aims 
The aim of our study was to determine the prevalence 
of hepatitis B surface antigen within the sub-populations 
of pregnant women and intra-venous drug abusers. 
Although pregnant women are a selected population, 
they are likely to represent a healthy cohort within the 
general population, whereas, intravenous drug abusers 
represent a high risk group. It is probable therefore, that 
the results obtained would indicate that the approximate 
overall prevalence within the general Maltese population 
would lie within this range. 
Materials & Methods 
Serum samples were collected from pregnant women 
who were routinely screened for hepatitis B over a 
period of two years (January 1992 to December 1993). 
One thousand, two hundred and fifty-eight pregnant 
women aged 14 to 56 years (median of 29 years) were 
selected at random from those attending the "booking 
visit" at ante-natal clinics, SI. Luke's Hospital (SLH), 
Malta and Gozo General Hospital (GGH), Gozo. SI. 
Luke's Hospital is the only general hospital in Malta and 
the majority of births in Malta take place in this hospital. 
Hence, the random population chosen during the 
booking visit was considered representative of the 
population of pregnant women in Malta. 
In addition, 364 newly admitted drug addicts aged 16 
to 52 years (median: 25) attending the detoxification 
centre, SLH, Malta within this two year recruitment 
period were tested anonymously for the presence of 
HBsAg. The prevalence of intra-venous drug abusers at 
the time of the study was unknown. However, 
according to unpublished figures (SEDQA) the 
estimated prevalence today, is about 600. Therefore, 
given the probability that there were less cases then, the 
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number investigated (364) is a fair representative 
sample. 
An enzyme immuno assay, (Auszyme® Abbott 
Laboratories) was used to detect HBsAg levels in 
concentrations of ~ 0.lng/mI6. A positive EIA reaction 
was repeated and if the repeat test was also positive a 
confirmatory neutralization test was carried out. 
Student's Hest was used to determine significant 
association or difference between the age of seropositive 
and seronegative individuals within both cohorts. 
Results 
Of the 1258 pregnant women tested, eight were found 
to be positive for the surface antigen resulting in a 
prevalence of HBsAg of 6 per 1000 women within this 
cohort. There was no significant difference between the 
ages of the seropositive and seronegative women. 
Ten of the 364 drug abusers were positive for HBsAg 
indicating an approximate prevalence of 30/1000. There 
was a significant difference between the mean age of the 
seropositive (32.4 years) and seronegative (26.41 years) 
drug addicts at P<0.025%. 
Discussion 
Malta is an island nation with a population of 
approximately 360,000. It is geographically surrounded 
by areas of intermediate endemicity carrier rates, 
including southern Italy, Northern Africa and the Middle 
East. WHO considers an intermediate prevalence rate to 
lie between 2 - 7%8 and so by applying a prevalence of 
approximately 4% to Malta, it would be expected that 
14,400 persons would be carriers of this infection. 
In order to carry out a comprehensive evaluation of the 
entire Maltese . population, the use of invasive 
serological techniques would have rendered such a study 
extremely difficult. For this reason the subpopulations 
of pregnant women and drug addicts were chosen. 
Pregnant Women Population 
The prevalence of 6/1 000 with hepatitis B antigen 
positivity in this cohort was low compared with the 
higher rates present in neighbouring countries. This 
study population sample was large enough for this rate 
to be considered a valid representation of that of all 
pregnant women attending St. Luke's Hospital and 
therefore on the island. Perinatal transmission of HBV 
represents one of the most efficient modes of hepatitis B 
transmission and approxin1ately 90% of HBeAg carrier 
mothers infect their infants in this way9. As a result, 85 
to 90% of infected infants will themselves become 
chronic carriers probably as a result of their immature 
immune system which is unable to eliminate the surface 
antigens5.9.lo. Serological studies involving women of 
child bearing age are a useful scientific guide for the 
estimation of risk of infection to infants by perinatal 
transmission8. In this study, eight previously undetected 
HBsAg positive women were identified and their 
offspring were immunized within 48 hours of birth, 
thereby preventing future complications related to the 
infection9.I I. 
Indeed the administration, concurrently, of 
immunoglobulin (HBIG) preparation and the vaccine to 
infants of HBsAg positive mothers, within 48 hours and 
not later than 7 days of birth, prevents the development 
of carrier states in all but 5% of such exposed 
infants3,4,9,1l. A second dose of the vaccine is then 
administered at 1-2 months of age, and a third at 6-18 
months of age ll . The aim of immunization is the 
protection against HBsAg carrier status and thus 
reduction of carcinoma associated with the chronic 
infection. 
Drug Abuse Population 
This study has shown that an approximate 30/1000 
drug addicts in Malta were positive for the surface 
antigen. This value is considerably higher than the 
prevalence of HBsAg shown within the cohort of 
pregnant women, and confirms the high risk of this 
infection in drug abusers in Malta 12 . However, when 
compared with the prevalence of HBsAg of 38% within 
a similar addict popUlation in Stockholm13, the 
prevalence in Malta was approximately 3%. Due to the 
fact that information regarding drug addicts is withheld 
to preserve anonymity, it was not possible to trace data 
about exposure to other risk factors. For this reason it 
was assumed that these persons contracted the infection 
as a result of their lifestyle involving drug abuse. 
The mean age of seropositive drug addicts was 
significantly greater than that of their seronegative 
counterparts. Recently, the detoxification centre in 
Malta has provided patients with free syringes so as to 
avoid the sharing of contaminated equipment, thereby 
reducing the spread of infection. Also a public 
education programme about hepatitis B and its modes of 
transmission has resulted in an increased awareness of 
the risks associated with this lifestyle. Older drug 
abusers may have been exposed to these risk factors for 
a longer period of time as compared to younger persons, 
and as in other countries with a low to intermediate 
prevalence carrier popUlation, hepatitis B infection 
increases with age. However, as the study only looked 
at addicts attending the detoxification centre at SLH, it 
may not be representative of the drug abusing 
population on the island as a whole. 
Conclusion 
These two serological studies have provided 
prevalence rates of two extremes of the Maltese 
population. It may be assumed that the overall 
prevalence lies somewhere between the rate for pregnant 
women and that of the sub-popUlation of drug addicts . 
From this, one may assume that the overall popUlation 
prevalence rate lies between 1 % and 3% which is a low 
or low-intermediate endemicity rate as set by WHO. 
References 
1. 	 Zuckennan AI, Zuckerman I & Harrison T. Viral 
hepatitis - the alphabet so far; Int I of Cl in Virol 1993; 6: 
1-8. 
2. 	 Cook Gc. Infections involving the liver and biliary 
system; communicable and tropical diseases, 101-115. 
3. 	 McCollum RW. Viral hepatitis, epidemiology and 
control, 1989. 
4. 	 Smithkline Beecham Biologicals Documenta: New 
prospects for control of Hepatitis B, 1989. 
27 Hepatitis B prevalence in two Maltese sub-populations 
5. 	 Maynard M. Hepatitis B vaccine: Current progress and 
strategies for utilisation. New developments with human 
and veterinary vaccines, 157-168. 
6. 	 Hoofnagle JH & DiBisceglie AM. Serological diagnosis 
of acute and chronic viral Hepatitis; Seminars in liver 
disease, 1991; 1I(2): 73-83. 
7. 	 Farrugia A. Incidence of Hepatitis B surface antigen in 
Maltese blood donors - results comparing different test 
systems, pp54-61, in Camilleri M (ed)., Clinical 
Gastroenterology in Malta. Malta, 1987. 
8. 	 WHO: Immunisation. WHO EPI/Gen/88.5: 4-23. 
9. 	 Emest JM et al. Intrapartum Hepatitis B screening in a 
low-risk population. Amer J of Obs and Gynae 1990; 
978-980. 
10. 	 Beasley et al. Hepatology, 3(2): 135-141. 
11. 	 Committee on Infectious Diseases: Universal Hepatitis B 
Immunisation. Amer Acad of Paediat 1992; 89(4): 795­
800. 
12. 	 Zuckemlan AJ. Immunisation against Hepatitis B. Br 
Med Bulletin, 1990; 46: 383-398. 
13. 	 Sobeslavsky o. Prevalence of markers of Hepatitis B 
virus infection in various countries: a WHO Collaborative 
Study. Bulletin of the World Health Organisation 1980; 
58(4): 621-628. 
Hospices and hospitals 
St Anne House, Senglea (Ospizio Sant Anna) 
The Ospizio is situated on the Senglea Wharf facing 
Vittoriosa. Opened in 1794, in the house bequeathed by 
Nicola and Maddalena Dingli, it originally housed 
women from Senglea and Siggiewi, Nicola Dingli's 
native village. In 1889 it was taken over by the 
Franciscan Sisters of Malta who ran it for over 70 years . 
The building became unsuitable for its purpose and in 
1980, the Archpriest of Senglea, Fr. John Sladden, 
assisted by Canon Vincent Camilleri, decided to build a 
new hospital on the site. 1lle new building, designed by 
Architect Joseph Borg Constanzi, was inaugurated in 
1987 and can take 30 inmates. Two lions from the old 
building, holding the stems of the Dingli and Comelio 
families, have been incorporated in the front gate. Since 
1987 it has been administered by Movement Umanita 
Gdida which is a branch of the Focolare movement. 
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